SCHEMBL12374703

SCHEMBL12374703

CC(=O)c1c(C)c(C)c(C)n(C)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.42
TSHR P16473 3/20 0.41
ALDH1A1 P00352 2/20 0.40
KMT2A Q03164 4/20 0.34
MEN1 O00255 3/20 0.34
LMNA P02545 3/20 0.34
POLB P06746 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
EGFR P00533 1/20 0.33
SRC P12931 1/20 0.33
HTT P42858 1/20 0.33
USP2 O75604 1/20 0.33
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
RECQL P46063 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL474758 0.74 KDM4E (0.47) KDM4ETSHRALDH1A1KMT2AMEN1
SCHEMBL10049703 0.73 KDM4E (0.32) KDM4EALDH1A1KMT2AMEN1
SCHEMBL30932977 0.72 CYP3A4 (0.46) KDM4ETSHRALDH1A1KMT2AMEN1
SCHEMBL11893177 0.72 CYP3A4 (0.46) KDM4ETSHRALDH1A1KMT2AMEN1
SCHEMBL12417723 0.72 ALDH1A1 (0.46) KDM4ETSHRALDH1A1KMT2AMEN1
SCHEMBL31384761 0.71 LDHA (0.43) KDM4ETSHRALDH1A1KMT2AMEN1
SCHEMBL15959641 0.70 KMT2A (0.38) KDM4ETSHRKMT2AMEN1LMNA
SCHEMBL19149846 0.69 CYP3A4 (0.48) KDM4ETSHRALDH1A1KMT2AMEN1
SCHEMBL14288822 0.69 ALDH1A1 (0.71) KDM4ETSHRALDH1A1KMT2AMEN1
SCHEMBL1400072 0.67 KDM4E (0.49) KDM4ETSHRALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989478-B2 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-08-02 US disclosed
US-20080103139-A1 3-Carbamoyl-2-Pyridone Derivative SHIONOGI & CO. LTD. (JP) 2008-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080103139-A1 3-Carbamoyl-2-Pyridone Derivative CNR1, CNR2, HRH4 KDM4E 1522/4885TSHR 1109/4885ALDH1A1 4132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.